Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Ralpha). It enhances antibody-dependent cell-mediated cytotoxicity, leading to a rapid depletion of eosinophils. Benralizumab is used for severe eosinophilic asthma and can be employed to prevent exacerbations of chronic obstructive pulmonary disease.
Purity:
>95%
CAS Number:
[1044511-01-4]
Target:
IL Receptor|||Apoptosis|||Interleukin
T10497
T10497
* VAT and and shipping costs not included. Errors and price changes excepted
